We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

41 hedge funds and large institutions have $8.55M invested in Checkpoint Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

129% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 7

17% more funds holding

Funds holding: 35 → 41 (+6)

0.05% less ownership

Funds ownership: 1.23% → 1.18% (-0.05%)

9% less capital invested

Capital invested by funds: $9.4M → $8.55M (-$849K)

Holders
41
Holders Change
+6
Holders Change %
+17.14%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
16
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$374K
2
Northern Trust
Northern Trust
Illinois
+$259K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$121K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$74.8K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$60.5K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$535K
2
Renaissance Technologies
Renaissance Technologies
New York
-$129K
3
PAS
Park Avenue Securities
New York
-$93K
4
JP Morgan Chase
JP Morgan Chase
New York
-$82.7K
5
Millennium Management
Millennium Management
New York
-$71.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Victory Capital Management
26
Victory Capital Management
Texas
$20K +$24K +1,358 New
Deutsche Bank
27
Deutsche Bank
Germany
$18K +$5.31K +300 +35%
SG Americas Securities
28
SG Americas Securities
New York
$18K +$21.5K +1,212 New
Barclays
29
Barclays
United Kingdom
$17K -$23.6K -1,334 -55%
Mackenzie Financial
30
Mackenzie Financial
Ontario, Canada
$16K +$19.1K +1,077 New
Truist Financial
31
Truist Financial
North Carolina
$15K – – –
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$13.1K +$9.86K +557 +179%
PAM
33
Panagora Asset Management
Massachusetts
$13K +$14.9K +840 New
JP Morgan Chase
34
JP Morgan Chase
New York
$12K -$82.7K -4,673 -86%
Morgan Stanley
35
Morgan Stanley
New York
$12K -$45.7K -2,582 -77%
Osaic Holdings
36
Osaic Holdings
Arizona
$11K +$13.5K +760 New
SO
37
STRS Ohio
Ohio
$9K – – –
Citigroup
38
Citigroup
New York
$8K +$1.08K +61 +12%
Legal & General Group
39
Legal & General Group
United Kingdom
$7K – – –
AIP
40
Ameritas Investment Partners
Nebraska
$3K – – –
MAM
41
Meeder Asset Management
Ohio
$1K +$1.63K +92 New
AFM
42
Anson Funds Management
Texas
– -$535K -31,125 Closed
PAS
43
Park Avenue Securities
New York
– -$93K -5,383 Closed
Bank of Montreal
44
Bank of Montreal
Ontario, Canada
– -$6K -321 Closed
1
2

CKPT Hedge Fund Activity: Q1 2020 in Review

41 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q1 2020, worth a combined $8.55M — down 9% from $9.4M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CKPT positions and 3 closed out — a net gain of 6 holders — while 16 added to existing stakes and 7 trimmed.

The largest buyer was BlackRock, adding an estimated $374K. The largest seller was Anson Funds Management, exiting entirely with an estimated $535K sold.

  • 41 institutional investors held Checkpoint Therapeutics (CKPT) as of Q1 2020, up from 35 in Q4 2019.
  • Funds reported $8.55M of Checkpoint Therapeutics stock for Q1 2020, down 9% quarter-over-quarter.
  • 9 funds opened new Checkpoint Therapeutics positions in Q1 2020 and 3 closed out, a net change of +6 holders.
  • The largest Checkpoint Therapeutics buyer in Q1 2020 was BlackRock, an estimated $374K added.
  • The largest Checkpoint Therapeutics seller in Q1 2020 was Anson Funds Management, an estimated $535K sold.

Based on aggregated 13F filings for Q1 2020.